JillSamisMD
Pediatric Endocrinology • Chicago, ILPediatric Diabetes Endocrinology, Pediatric Growth Disorder Endocrinology, Pediatric Thyroid Endocrinology
Physician
Dr. Samis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
225 E Chicago Ave
# 54
Chicago, IL 60611Phone+1 312-227-6090Fax+1 312-227-9403
Summary
- Dr. Jill Samis is a pediatric endocrinologist in Chicago, IL and is affiliated with multiple hospitals in the area, including Ann & Robert H. Lurie Children’s Hospital of Chicago and Ann & Robert H. Lurie Children's Hospital of Chicago. She received her medical degree from Emory University School of Medicine and has been in practice 11 years. She specializes in pediatric diabetes endocrinology, pediatric growth disorder endocrinology, and pediatric thyroid endocrinology.
Education & Training
McGaw Medical Center of Northwestern UniversityFellowship, Pediatric Endocrinology, 2009 - 2012- McGaw Medical Center of Northwestern UniversityResidency, Pediatrics, 2006 - 2009
Emory University School of MedicineClass of 2006
Certifications & Licensure
IL State Medical License 2008 - 2026- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Endocrinology
Publications & Presentations
PubMed
- Assessing national trends in indications for pediatric total thyroidectomy.Christopher Puchi, Mehul V Raval, Yao Tian, Jami Josefson, Jill Samis
American Journal of Otolaryngology. 2024-07-24 - One children's hospital planning and development process to adhere to the FDA recommendation that babies and young children undergo thyroid function testing after rece...Dianna M E Bardo, Jill H Samis, Jami L Josefson, Marcelo R Malakooti, Paul Tannous
Pediatric Radiology. 2024-01-01 - 1 citationsThe long-term efficacy and safety of nilotinib in pediatric patients with CML: a 5-year update of the DIALOG study.Nobuko Hijiya, Alexey Maschan, Carmelo Rizzari, Hiroyuki Shimada, Carlo Dufour
Blood Advances. 2023-12-12
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
